Nikkei 225

Olympus

A Japanese medical and optics company making endoscopes and other medical and precision optical devices. Nikkei 225 constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.

7733.T Updated Jul 11, 2026 2 AI consumers· 1 recurring

Annual return · 2026-07-10'21+35.5%'22-4.1%'23-8.8%'24+8.5%'25-21.4%YTD-2.8%
Money in·
Olympus~¥950B
Money out·

Financials & Segments

  • Total revenue · ~¥950B (FY2024)
  • Segments · Endoscopy · Therapeutic Devices

Revenue from

No refined links yet.

Pays to

No refined links yet.


← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com